According to the warning letter, Medtronic failed to correct a flaw in its SynchroMed II infusion pump and properly document and investigate more than 560 complaints about the device.
Medtronic is working to resolve the complaints and implement corrective action to improve its investigative process, according to a company spokeswoman.
More Articles on Devices:
TransCorp Spine Granted U.S. Patent for SpinePort MIS Access System
Wright Medical Group Announces $200M in Senior Notes
Globus Medical 2Q Sales Climb 18.6% to $96M
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.